244 related articles for article (PubMed ID: 36224639)
1. CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.
Sorrentino C; D'Antonio L; Ciummo SL; Fieni C; Landuzzi L; Ruzzi F; Vespa S; Lanuti P; Lotti LV; Lollini PL; Di Carlo E
J Hematol Oncol; 2022 Oct; 15(1):145. PubMed ID: 36224639
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
Ciummo SL; Sorrentino C; Fieni C; Di Carlo E
J Exp Clin Cancer Res; 2023 Dec; 42(1):336. PubMed ID: 38087324
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival.
D'Antonio L; Fieni C; Ciummo SL; Vespa S; Lotti L; Sorrentino C; Di Carlo E
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36927528
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.
Sorrentino C; Ciummo SL; Cipollone G; Caputo S; Bellone M; Di Carlo E
Cancer Res; 2018 May; 78(10):2654-2668. PubMed ID: 29487200
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome.
Sorrentino C; Ciummo SL; D'Antonio L; Fieni C; Lanuti P; Turdo A; Todaro M; Di Carlo E
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663639
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
[TBL] [Abstract][Full Text] [Related]
7. Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression.
Yahata T; Mizoguchi M; Kimura A; Orimo T; Toujima S; Kuninaka Y; Nosaka M; Ishida Y; Sasaki I; Fukuda-Ohta Y; Hemmi H; Iwahashi N; Noguchi T; Kaisho T; Kondo T; Ino K
Cancer Sci; 2019 Apr; 110(4):1279-1292. PubMed ID: 30702189
[TBL] [Abstract][Full Text] [Related]
8. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.
Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W
Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439
[TBL] [Abstract][Full Text] [Related]
9. Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization.
Fierro J; DiPasquale J; Perez J; Chin B; Chokpapone Y; Tran AM; Holden A; Factoriza C; Sivagnanakumar N; Aguilar R; Mazal S; Lopez M; Dou H
Sci Rep; 2022 Feb; 12(1):2417. PubMed ID: 35165339
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-30 Promotes Breast Cancer Growth and Progression.
Airoldi I; Cocco C; Sorrentino C; Angelucci D; Di Meo S; Manzoli L; Esposito S; Ribatti D; Bertolotto M; Iezzi L; Natoli C; Di Carlo E
Cancer Res; 2016 Nov; 76(21):6218-6229. PubMed ID: 27550449
[TBL] [Abstract][Full Text] [Related]
11. Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival.
Sorrentino C; Yin Z; Ciummo S; Lanuti P; Lu LF; Marchisio M; Bellone M; Di Carlo E
J Immunother Cancer; 2019 Jul; 7(1):201. PubMed ID: 31366386
[TBL] [Abstract][Full Text] [Related]
12. CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway.
Kuo PL; Chen YH; Chen TC; Shen KH; Hsu YL
J Cell Physiol; 2011 May; 226(5):1224-31. PubMed ID: 20945384
[TBL] [Abstract][Full Text] [Related]
13. Targeting CXCL5 in Pancreatic Cancer Cells Inhibits Cancer Xenograft Growth by Reducing Proliferation and Inhibiting EMT Progression.
Wang ZZ; Li XT; Li QJ; Zhou JX
Dig Dis Sci; 2023 Mar; 68(3):841-851. PubMed ID: 35650416
[TBL] [Abstract][Full Text] [Related]
14. Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes.
Liu CW; Peng HY; Siao AC; Tsuei YW; Lin YY; Shiah SG; Shih LJ; Yeh CC; Lee SW; Kao YH
Exp Biol Med (Maywood); 2023 Oct; 248(20):1695-1707. PubMed ID: 37646261
[TBL] [Abstract][Full Text] [Related]
15. Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
Wang G; Lu X; Dey P; Deng P; Wu CC; Jiang S; Fang Z; Zhao K; Konaparthi R; Hua S; Zhang J; Li-Ning-Tapia EM; Kapoor A; Wu CJ; Patel NB; Guo Z; Ramamoorthy V; Tieu TN; Heffernan T; Zhao D; Shang X; Khadka S; Hou P; Hu B; Jin EJ; Yao W; Pan X; Ding Z; Shi Y; Li L; Chang Q; Troncoso P; Logothetis CJ; McArthur MJ; Chin L; Wang YA; DePinho RA
Cancer Discov; 2016 Jan; 6(1):80-95. PubMed ID: 26701088
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer.
Camargo JA; Viana NI; Pimenta R; Guimarães VR; Dos Santos GA; Candido P; Ghazarian V; Romão P; Silva IA; Birbrair A; Srougi M; Nahas WC; Leite KR; Trarbach EB; Reis ST
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834295
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone.
Roca H; Jones JD; Purica MC; Weidner S; Koh AJ; Kuo R; Wilkinson JE; Wang Y; Daignault-Newton S; Pienta KJ; Morgan TM; Keller ET; Nör JE; Shea LD; McCauley LK
J Clin Invest; 2018 Jan; 128(1):248-266. PubMed ID: 29202471
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairing effect in human prostate cancer cell line PC-3.
Batır MB; Şahin E; Çam FS
Mol Biol Rep; 2019 Dec; 46(6):6471-6484. PubMed ID: 31571107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
